Société Générale — M&A Activity 2021

Feb 11, 2021

National Storage Mechanism | Additional information

RNS Number : 8037O

Societe Generale SA

11 February 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.000304635 ordinary shares
Date of dealing	10/02/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	897,602	0.70	2,654	0.00
(2) Derivatives (other than options)	1,410	0.00	8,131	0.01
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*1,495,376	*1.16	10,785	0.01

* Include the holding of shares 596,364 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	7	227.18
Purchase	32	225.34
Purchase	1,348	225.63
Purchase	2	225.63
Purchase	75	227.16
Purchase	25	227.17
Purchase	2	230.552
Purchase	14	230.552
Purchase	22	230.552
Purchase	100	227.34
Purchase	100	227.29
Purchase	40	228.55
Purchase	50	228.55
Purchase	10	228.55
Purchase	100	228.73
Purchase	100	228.87
Purchase	100	228.88
Purchase	39	228.47
Purchase	61	228.47
Purchase	9	227.27
Purchase	91	227.27
Purchase	5	230.15
Purchase	100	226.6
Purchase	100	225.63
Purchase	115	229.77
Purchase	31	229.77
Purchase	38	229.77
Purchase	203	229.77
Purchase	179	229.77
Purchase	9	228.3
Purchase	4	229.01
Purchase	87	229.01
Purchase	1	229.02
Purchase	1	229.02
Purchase	26	229.02
Purchase	9	229.01
Purchase	100	225.28
Purchase	16	228.82
Purchase	33	228.83
Purchase	32	228.83
Purchase	34	227.28
Purchase	16	227.2
Purchase	100	227.24
Purchase	20	228.5
Purchase	48	227.2
Purchase	52	227.2
Purchase	100	228.05
Purchase	16	227.34
Purchase	20	227.34
Purchase	44	227.34
Purchase	20	227.34
Purchase	30	229.47
Purchase	46	229.47
Purchase	24	229.47
Purchase	32	228.51
Purchase	68	228.51
Purchase	24	228.11
Purchase	97	227.38
Purchase	60	228.43
Purchase	9	228.43
Purchase	6	228.43
Purchase	100	228.98
Purchase	100	228.43
Purchase	100	227.19
Purchase	100	227.42
Purchase	3	227.38
Purchase	17	229.75
Purchase	83	229.75
Purchase	2,508	225.63
Purchase	1,216	225.63
Purchase	406	225.63
Sale	1,682	225.63
Sale	1,520	225.63
Total Purchases	8,915
Total Sales	3,202

(b)      Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit USD (Note 5)
Euro Medium Term Note	Increased long	2	225.63

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	11/02/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFLFVIFSILLIL